177 related articles for article (PubMed ID: 12833226)
1. [Disability and quality of life in patients with migraine: determining factors].
Fernández-Concepción O; Canuet-Delis L
Rev Neurol; 2003 Jun 16-30; 36(12):1105-12. PubMed ID: 12833226
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
[TBL] [Abstract][Full Text] [Related]
4. Predicting disability and quality of life in a community-based sample of women with migraine headache.
Kolotylo CJ; Broome ME
Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
[TBL] [Abstract][Full Text] [Related]
5. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
6. Disability and quality of life in different primary headaches: results from Italian studies.
Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
[TBL] [Abstract][Full Text] [Related]
7. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine.
Gedikoglu U; Coskun O; Inan LE; Ucler S; Tunc T; Emre U
Cephalalgia; 2005 Jun; 25(6):452-6. PubMed ID: 15910570
[TBL] [Abstract][Full Text] [Related]
9. Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: comparison with episodic migraine.
Canuet L; Ishii R; Fernandez-Concepcion O; Iwase M; Takeda M
Psychiatry Clin Neurosci; 2008 Dec; 62(6):738-40. PubMed ID: 19068012
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.
Lipton RB; Stewart WF; Sawyer J; Edmeads JG
Headache; 2001 Oct; 41(9):854-61. PubMed ID: 11703471
[TBL] [Abstract][Full Text] [Related]
11. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
12. Headache prophylaxis with BoNTA: patient characteristics.
Silberstein SD; Marmura MJ; Shaw J; Yu S
Headache; 2010 Jan; 50(1):63-70. PubMed ID: 19549156
[TBL] [Abstract][Full Text] [Related]
13. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
[TBL] [Abstract][Full Text] [Related]
14. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Short Form-36 and Migraine Disability Assessment questionnaire in patients with migraine.
Fuh JL; Wang SJ
Clin J Pain; 2006; 22(6):564-8. PubMed ID: 16788344
[TBL] [Abstract][Full Text] [Related]
16. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
De Diego EV; Lanteri-Minet M
Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
[TBL] [Abstract][Full Text] [Related]
17. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura.
D'Amico D; Grazzi L; Usai S; Rigamonti A; Curone M; Bussone G
Headache; 2005 May; 45(5):553-60. PubMed ID: 15953274
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of migraine.
Dowson AJ
Curr Med Res Opin; 2001; 17(4):298-309. PubMed ID: 11922404
[TBL] [Abstract][Full Text] [Related]
19. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.
Usai S; Grazzi L; Andrasik F; D'Amico D; Rigamonti A; Bussone G
Neurol Sci; 2004 Oct; 25 Suppl 3():S272-3. PubMed ID: 15549557
[TBL] [Abstract][Full Text] [Related]
20. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
MacGregor EA; Brandes J; Eikermann A; Giammarco R
Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
